drugset / Trial / NCT02559934
Multiple-dose Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis
NaSingle-groupOpen-labelTreatment
Summary
The aim of this study is to assess the delivery of SR-T100 from the topical gel (containing 2.3% solamargine in Solanum undatum plant extract) by determining the plasma levels of solamargine in subjects with AK while administration of a 25 cm2 contiguous or non-contiguous dermal treatment area.
Timeline
- Start
- 2015-11
- Primary completion
- 2019-01
- Completion
- 2019-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | solamargine | Small molecule | 0.3 g | Topical |
| Subject | solamargine | Small molecule | 0.5 g | Topical |